SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investors focus on the company's strategic pivot toward AI infrastructure following its acquisition of Northern Data, a move that has significantly expanded its GPU capacity and data center footprint. The community is actively debating the potential for a massive short squeeze due to record-high short interest, while simultaneously analyzing the upcoming earnings report and formal guidance as key catalysts for a long-term re-rating.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Platforms is seeing significant investor interest following a major 20-year data center lease with Anthropic, a move the community views as a pivotal shift toward AI infrastructure. While bullish traders point to the potential of upcoming facility contracts to drive long-term value, others express frustration over recent price volatility and are actively debating the company's execution timeline and future dilution risks.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi is experiencing significant market interest following the announcement of a 15-year binding lease agreement with TensorWave worth approximately $6.5 billion in contracted revenue. The community is actively debating the stock's future, with many interpreting the deal as a major validation of the company's Project Matador infrastructure while others remain cautious regarding execution timelines and potential share dilution.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is facing extreme volatility after missing revenue expectations for the first time since going public, with investors weighing the company's strong margins and AI growth narrative against a wave of analyst downgrades. The community is sharply divided, with many traders framing the sharp sell-off as an irrational overreaction and a long-term buying opportunity, while others warn of slowing growth and potential for further downside.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently the center of active community debate as investors weigh record revenue and a massive backlog against concerns over Neutron launch timelines and short-term profitability. While some retail traders see the recent dip as a strategic entry point, others are cautious about execution risks, with the community closely monitoring the management team's commentary on upcoming operational milestones.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the B&W segment. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is seeing significant momentum as investors digest a strong backlog growth and a strategic collaboration with Siemens Energy to supply turbines for AI data center infrastructure. The community is actively debating the company's turnaround, with many traders highlighting the stock's resilience and potential for further gains as it capitalizes on the surging demand for power capacity.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is currently generating significant investor debate ahead of its upcoming earnings report, with sentiment split between those focusing on aggressive revenue growth and international expansion and those concerned about margin compression and recent regulatory headwinds. The community remains hyper-focused on the company's ability to execute on its long-term targets while navigating short-term EPS volatility.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is currently experiencing high volatility and intense community debate as the price hovers near a key psychological support level of one dollar. Investors are deeply divided, with some actively accumulating during the pullback while others express frustration over delayed regulatory clarity and stagnant price action.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

On Holding shares have faced downward pressure following the resignation of the CEO, a move that surprised investors and triggered a leadership transition back to the company's founders as co-CEOs. While the community remains divided over the stability of this management shift, bulls emphasize the company's strong innovation pipeline and global brand momentum as core reasons to remain invested through the volatility.

Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.

Sionna Therapeutics Inc.

Sionna Therapeutics Inc

Sionna Therapeutics is experiencing significant volatility following a sharp sell-off triggered by the discontinuation of its SION-719 cystic fibrosis drug program due to unfavorable clinical trial data. The community is actively debating whether the stock is a 'dead cat bounce' play or an undervalued opportunity, frequently highlighting the company's remaining cash position and pipeline potential as catalysts for a potential rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rani Therapeutics CFO Svai Sanford Steps Down, Nicholas Maestas Appointed As Successor

(RTTNews) - Rani Therapeutics Holdings, Inc. (RANI) said on Monday that Chief Financial Officer Svai Sanford has stepped down. Following this, the company has appointed Nicholas Maestas as successor, effective immediately...

Rani Therapeutics (RANI) Projected to Post Earnings on Wednesday

Rani Therapeutics (NASDAQ:RANI) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-13-rani-therapeutics-holdings-inc-stock...

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) have earned an average rating of "Moderate Buy" from the six ratings firms that are presently covering the company...

Rani Therapeutics (NASDAQ:RANI) Earns Buy Rating from Analysts at Lake Street Capital

Lake Street Capital initiated coverage on Rani Therapeutics in a research report on Tuesday. They set a "buy" rating and a $9.00 price target on the stock...

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five brokerages that are currently covering the company...

Canaccord Genuity Group Lowers Rani Therapeutics (NASDAQ:RANI) Price Target to $5.00

Canaccord Genuity Group lowered their target price on Rani Therapeutics from $9.00 to $5.00 and set a "buy" rating for the company in a report on Wednesday...

Equities Analysts Offer Predictions for RANI Q1 Earnings

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Free Report) - HC Wainwright issued their Q1 2026 earnings per share estimates for shares of Rani Therapeutics in a report issued on Friday, March...

Rani Therapeutics (NASDAQ:RANI) Given "Buy" Rating at HC Wainwright

HC Wainwright reissued a "buy" rating and issued a $11.00 price target on shares of Rani Therapeutics in a research report on Friday...

Rani Therapeutics Q4 Earnings Call Highlights

Rani Therapeutics (NASDAQ:RANI) executives highlighted what they described as a transformational 2025 during the company's fourth-quarter and full-year earnings call, pointing to progress advancing...

Rani Therapeutics (NASDAQ:RANI) Announces Quarterly Earnings Results

Rani Therapeutics (NASDAQ:RANI - Get Free Report) posted its earnings results on Thursday. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.02). The...

Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.

Rani Therapeutics Holdings Inc - Ordinary Shares Class A

Why Is Rani Therapeutics’ Stock Skyrocketing Pre-Market Today?

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.7899
Prev Close	$0.7769
Open	$0.7782
Dividend Yield	0.00%
50-Day Moving Average	$0.7791
Beta	1.70
Avg. Volume	1.04M
PE Ratio	-1.90

52-Week High	$3.87
52-Week Low	$0.4404
Market Capitalization	$105.94M
EPS (Annual)	-$0.4486
Price to Book	2.73
Revenue Per Employee	$23,000.00

Feed

News

Sentiment

Earnings

Fundamentals

Info